CC
Cipher Capital Portfolio holdings
AUM
$216M
This Quarter Return
+7.71%
1 Year Return
+23.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$216M
AUM Growth
+$216M
(-30%)
Cap. Flow
-$106M
Cap. Flow
% of AUM
-49.14%
Top 10 Holdings %
Top 10 Hldgs %
10.54%
Holding
654
New
171
Increased
84
Reduced
155
Closed
243
Top Buys
| 1 |
Apple
AAPL
|
$2.37M |
| 2 |
Applied Materials
AMAT
|
$2.31M |
| 3 |
WEC Energy
WEC
|
$1.92M |
| 4 |
HP
HPQ
|
$1.71M |
| 5 |
Lam Research
LRCX
|
$1.61M |
Top Sells
| 1 |
MetLife
MET
|
$5.36M |
| 2 |
Prudential Financial
PRU
|
$3.62M |
| 3 |
NVIDIA
NVDA
|
$3.26M |
| 4 |
Eli Lilly
LLY
|
$2.93M |
| 5 |
Lockheed Martin
LMT
|
$2.9M |
Sector Composition
| 1 | Technology | 18.97% |
| 2 | Financials | 17.78% |
| 3 | Industrials | 12.66% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Healthcare | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
AerCap
AER
$22.2B
| $352K | 0.16% |
+4,054
| New | +$352K |
|
|
ELME
227
Elme Communities
ELME
$1.5B
| $351K | 0.16% |
25,200
-34,780
| -58% | -$484K |
|
228
Royalty Pharma
RPRX
$15.6B
| $350K | 0.16% |
11,515
-4,953
| -30% | -$150K |
|
229
Udemy
UDMY
$1.02B
| $350K | 0.16% |
31,846
-7,232
| -19% | -$79.4K |
|
230
Regeneron Pharmaceuticals
REGN
$61.3B
| $349K | 0.16% |
363
-151
| -29% | -$145K |
|
231
McKesson
MCK
$86B
| $347K | 0.16% |
+647
| New | +$347K |
|
232
Nextracker
NXT
$9.87B
| $346K | 0.16% |
+6,152
| New | +$346K |
|
233
Albany International
AIN
$1.83B
| $344K | 0.16% |
+3,678
| New | +$344K |
|
|
234
Eli Lilly
LLY
$659B
| $343K | 0.16% |
441
-3,761
| -90% | -$2.93M |
|
235
Veracyte
VCYT
$2.37B
| $342K | 0.16% |
+15,443
| New | +$342K |
|
236
Blackstone
BX
$132B
| $341K | 0.16% |
+2,595
| New | +$341K |
|
237
Wingstop
WING
$8.9B
| $340K | 0.16% |
927
-1,973
| -68% | -$723K |
|
|
SQSP
238
DELISTED
Squarespace, Inc.
SQSP
| $338K | 0.16% |
9,289
-1,640
| -15% | -$59.8K |
|
239
Bank OZK
OZK
$5.9B
| $338K | 0.16% |
7,443
+1,500
| +25% | +$68.2K |
|
240
Thermo Fisher Scientific
TMO
$184B
| $332K | 0.15% |
+572
| New | +$332K |
|
241
EPAM Systems
EPAM
$9.73B
| $332K | 0.15% |
1,203
-1,364
| -53% | -$377K |
|
242
Elevance Health
ELV
$72.6B
| $329K | 0.15% |
635
-3,581
| -85% | -$1.86M |
|
243
Stryker
SYK
$149B
| $326K | 0.15% |
910
-536
| -37% | -$192K |
|
244
GitLab
GTLB
$7.88B
| $325K | 0.15% |
5,581
-3,092
| -36% | -$180K |
|
245
Exelon
EXC
$43.8B
| $325K | 0.15% |
+8,658
| New | +$325K |
|
246
Parsons
PSN
$8.61B
| $325K | 0.15% |
3,918
+136
| +4% | +$11.3K |
|
247
United Bankshares
UBSI
$5.38B
| $325K | 0.15% |
9,071
+2,479
| +38% | +$88.7K |
|
248
Yelp
YELP
$1.98B
| $324K | 0.15% |
8,216
-6,865
| -46% | -$270K |
|
249
Integra LifeSciences
IART
$1.18B
| $324K | 0.15% |
9,129
-4,702
| -34% | -$167K |
|
250
Northrop Grumman
NOC
$84.4B
| $323K | 0.15% |
674
-2,669
| -80% | -$1.28M |
|